Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 160

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Kinetics of Antigen Expression and Epitope Presentation during Virus Infection

Open access
Croft, Nathan P., Smith, Stewart A., Wong, Yik Chun, Tan, Chor Teck, Dudek, Nadine L., Flesch, Inge E. A., Lin, Leon C. W., Tscharke, David C., Purcell, Anthony W. · 2013 · PLoS Pathogens

Abstract

Current knowledge about the dynamics of antigen presentation to T cells during viral infection is very poor despite being of fundamental importance to our understanding of anti-viral immunity. Here we use an advanced mass spectrometry method to simultaneously quantify the presentation of eight vaccinia virus peptide-MHC complexes (epitopes) on infected cells and the amounts of their source antigens at multiple times after infection. The results show a startling 1000-fold range in abundance as well as strikingly different kinetics across the epitopes monitored. The tight correlation between onset of protein expression and epitope display for most antigens provides the strongest support to date that antigen presentation is largely linked to translation and not later degradation of antigens. Finally, we show a complete disconnect between the epitope abundance and immunodominance hierarchy of these eight epitopes. This study highlights the complexity of viral antigen presentation by the host and demonstrates the weakness of simple models that assume total protein levels are directly linked to epitope presentation and immunogenicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1003129

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 77

  1. AW Purcell, 2008, Molecular machinations of the MHC-I peptide loading complex, Curr Opin Immunol, 20, 75, 10.1016/j.coi.2007.12.005 · doi:10.1016/j.coi.2007.12.005
  2. NL Dudek, 2010, Epitope discovery and their use in peptide based vaccines, Curr Pharm Des, 16, 3149, 10.2174/138161210793292447 · doi:10.2174/138161210793292447
  3. JW Yewdell, 2006, Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses, Immunity, 25, 533, 10.1016/j.immuni.2006.09.005 · DOI · Paper page
  4. DC Tscharke, 2005, Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines, J Exp Med, 201, 95, 10.1084/jem.20041912 · DOI · Paper page
  5. M Moutaftsi, 2006, A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus, Nat Biotechnol, 24, 817, 10.1038/nbt1215 · DOI · Paper page
  6. JM Vyas, 2008, The known unknowns of antigen processing and presentation, Nat Rev Immunol, 8, 607, 10.1038/nri2368 · DOI · Paper page
  7. AW Purcell, 2007, More than one reason to rethink the use of peptides in vaccine design, Nat Rev Drug Discov, 6, 404, 10.1038/nrd2224 · DOI · Paper page
  8. LC Anton, 1997, MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies, J Immunol, 158, 2535, 10.4049/jimmunol.158.6.2535 · DOI
  9. BP Dolan, 2012, MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA, Proceedings of the National Academy of Sciences, 109, 7025, 10.1073/pnas.1112387109 · DOI
  10. KC Pang, 2006, Dynamic quantification of MHC class I–peptide presentation to CD8+ T cells via intracellular cytokine staining, Journal of Immunological Methods, 311, 12, 10.1016/j.jim.2006.01.008 · doi:10.1016/j.jim.2006.01.008
  11. A Porgador, 1997, Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody, Immunity, 6, 715, 10.1016/S1074-7613(00)80447-1 · DOI · Paper page
  12. A Lev, 2010, Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action, Proc Natl Acad Sci U S A, 107, 6964, 10.1073/pnas.0910997107 · DOI
  13. O Makler, 2010, Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificity, Eur J Immunol, 40, 1552, 10.1002/eji.200939875 · doi:10.1002/eji.200939875
  14. Y Michaeli, 2009, Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 Complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies, J Immunol, 182, 6328, 10.4049/jimmunol.0801898 · DOI
  15. HD Hickman, 2003, Cutting edge: class I presentation of host peptides following HIV infection, J Immunol, 171, 22, 10.4049/jimmunol.171.1.22 · DOI
  16. CA van Els, 2000, A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains, Eur J Immunol, 30, 1172, 10.1002/(SICI)1521-4141(200004)30:4<1172::AID-IMMU1172>3.0.CO;2-J · doi:10.1002/(sici)1521-4141(200004)30:4<1172::aid-immu1172>3.0.co;2-j
  17. J Tellam, 2008, Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition, Proc Natl Acad Sci U S A, 105, 9319, 10.1073/pnas.0801968105 · DOI
  18. DP Granados, 2012, MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements, Blood, 119, e181, 10.1182/blood-2012-02-412593 · DOI
  19. D de Verteuil, 2012, Origin and plasticity of MHC I-associated self peptides, Autoimmun Rev, 11, 627, 10.1016/j.autrev.2011.11.003 · DOI
  20. BP Dolan, 2011, Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands, Cell Mol Life Sci, 68, 1481, 10.1007/s00018-011-0656-z · DOI
  21. BP Dolan, 2011, Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance, J Immunol, 186, 2065, 10.4049/jimmunol.1003096 · DOI
  22. DJ Farfan-Arribas, 2012, Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides, Proc Natl Acad Sci U S A, 109, 16998, 10.1073/pnas.1210271109 · DOI
  23. MH Fortier, 2008, The MHC class I peptide repertoire is molded by the transcriptome, J Exp Med, 205, 595, 10.1084/jem.20071985 · DOI · Paper page
  24. EA Reits, 2000, The major substrates for TAP in vivo are derived from newly synthesized proteins, Nature, 404, 774, 10.1038/35008103 · DOI · Paper page
  25. U Schubert, 2000, Rapid degradation of a large fraction of newly synthesized proteins by proteasomes, Nature, 404, 770, 10.1038/35008096 · DOI · Paper page
  26. S Khan, 2001, Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein, J Immunol, 167, 4801, 10.4049/jimmunol.167.9.4801 · DOI
  27. AO Weinzierl, 2007, Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface, Mol Cell Proteomics, 6, 102, 10.1074/mcp.M600310-MCP200 · DOI
  28. CC Norbury, 2002, Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo, Nat Immunol, 3, 265, 10.1038/ni762 · DOI · Paper page
  29. HD Hickman, 2008, Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes, Nat Immunol, 9, 155, 10.1038/ni1557 · DOI · Paper page
  30. RH Xu, 2010, Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response, PLoS Pathog, 6, e1000768, 10.1371/journal.ppat.1000768 · DOI
  31. CT Tan, 2011, Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring, Proteomics, 11, 2336, 10.1002/pmic.201000531 · DOI
  32. CC Norbury, 2004, CD8+ T cell cross-priming via transfer of proteasome substrates, Science, 304, 1318, 10.1126/science.1096378 · DOI · Paper page
  33. W Kastenmuller, 2007, Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination, J Exp Med, 204, 2187, 10.1084/jem.20070489 · DOI
  34. V Lange, 2008, Selected reaction monitoring for quantitative proteomics: a tutorial, Mol Syst Biol, 4, 222, 10.1038/msb.2008.61 · DOI · Paper page
  35. NL Dudek, 2012, Constitutive and Inflammatory Immunopeptidome of Pancreatic beta-Cells, Diabetes, 61, 3018, 10.2337/db11-1333 · DOI
  36. RD Unwin, 2005, Multiple reaction monitoring to identify sites of protein phosphorylation with high sensitivity, Mol Cell Proteomics, 4, 1134, 10.1074/mcp.M500113-MCP200 · DOI · Paper page
  37. Z Yang, 2010, Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing, Proc Natl Acad Sci U S A, 107, 11513, 10.1073/pnas.1006594107 · DOI · Paper page
  38. E Assarsson, 2008, Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes, Proc Natl Acad Sci U S A, 105, 2140, 10.1073/pnas.0711573105 · DOI
  39. Z Yang, 2011, Expression profiling of the intermediate and late stages of poxvirus replication, J Virol, 85, 9899, 10.1128/JVI.05446-11 · doi:10.1128/jvi.05446-11
  40. IE Flesch, 2012, Linear fidelity in quantification of anti-viral CD8+ T cells, PLoS One, 7, e39533, 10.1371/journal.pone.0039533 · DOI
  41. RM Chicz, 1992, Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size, Nature, 358, 764, 10.1038/358764a0 · DOI · Paper page
  42. AL Cox, 1994, Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines, Science, 264, 716, 10.1126/science.7513441 · DOI · Paper page
  43. VL Crotzer, 2000, Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines, J Immunol, 164, 6120, 10.4049/jimmunol.164.12.6120 · doi:10.4049/jimmunol.164.12.6120
  44. DF Hunt, 1992, Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry, Science, 255, 1261, 10.1126/science.1546328 · DOI · Paper page
  45. A Rudensky, 1991, Sequence analysis of peptides bound to MHC class II molecules, Nature, 353, 622, 10.1038/353622a0 · DOI · Paper page
  46. RG Urban, 1994, A subset of HLA-B27 molecules contains peptides much longer than nonamers, Proc Natl Acad Sci U S A, 91, 1534, 10.1073/pnas.91.4.1534 · doi:10.1073/pnas.91.4.1534
  47. KE Scull, 2012, Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands, Mol Immunol, 51, 136, 10.1016/j.molimm.2012.02.117 · DOI
  48. EZ Kincaid, 2011, Mice completely lacking immunoproteasomes show major changes in antigen presentation, Nat Immunol, 13, 129, 10.1038/ni.2203 · DOI · Paper page
  49. E Caron, 2011, The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation, Mol Syst Biol, 7, 533, 10.1038/msb.2011.68 · DOI
  50. KT Hogan, 2005, Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members, Cancer Immunol Immunother, 54, 359, 10.1007/s00262-004-0592-y · DOI
  51. CA Herberts, 2003, Dynamics of measles virus protein expression are reflected in the MHC class I epitope display, Mol Immunol, 39, 567, 10.1016/S0161-5890(02)00204-3 · doi:10.1016/s0161-5890(02)00204-3
  52. JW Yewdell, 2005, The seven dirty little secrets of major histocompatibility complex class I antigen processing, Immunol Rev, 207, 8, 10.1111/j.0105-2896.2005.00309.x · DOI
  53. TJ Yuen, 2010, Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response, J Virol, 84, 10220, 10.1128/JVI.01281-10 · DOI
  54. M Moutaftsi, 2009, Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model, Eur J Immunol, 39, 717, 10.1002/eji.200838815 · DOI
  55. HG Ljunggren, 1990, Empty MHC class I molecules come out in the cold, Nature, 346, 476, 10.1038/346476a0 · DOI · Paper page
  56. M Howarth, 2004, Tapasin enhances MHC class I peptide presentation according to peptide half-life, Proc Natl Acad Sci U S A, 101, 11737, 10.1073/pnas.0306294101 · DOI · Paper page
  57. HN Eisen, 2012, Promiscuous binding of extracellular peptides to cell surface class I MHC protein, Proc Natl Acad Sci U S A, 109, 4580, 10.1073/pnas.1201586109 · DOI
  58. S Apcher, 2011, Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation, Proc Natl Acad Sci U S A, 108, 11572, 10.1073/pnas.1104104108 · DOI · Paper page
  59. JW Yewdell, 2011, DRiPs solidify: progress in understanding endogenous MHC class I antigen processing, Trends Immunol, 32, 548, 10.1016/j.it.2011.08.001 · DOI · Paper page
  60. SI Mannering, 2005, The insulin A-chain epitope recognized by human T cells is posttranslationally modified, J Exp Med, 202, 1191, 10.1084/jem.20051251 · DOI · Paper page
  61. J Petersen, 2009, Post-translationally modified T cell epitopes: immune recognition and immunotherapy, J Mol Med (Berl), 87, 1045, 10.1007/s00109-009-0526-4 · DOI
  62. W Chen, 2000, Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses, Immunity, 12, 83, 10.1016/S1074-7613(00)80161-2 · DOI · Paper page
  63. SH van der Burg, 1996, Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability, J Immunol, 156, 3308, 10.4049/jimmunol.156.9.3308 · DOI · Paper page
  64. Y Yoshimura, 2004, Duration of alloantigen presentation and avidity of T cell antigen recognition correlate with immunodominance of CTL response to minor histocompatibility antigens, J Immunol, 172, 6666, 10.4049/jimmunol.172.11.6666 · DOI
  65. S Basta, 2002, Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8(+) T cells, J Immunol, 168, 5403, 10.4049/jimmunol.168.11.5403 · DOI
  66. W Chen, 2001, Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens, J Exp Med, 193, 1319, 10.1084/jem.193.11.1319 · DOI · Paper page
  67. M Groettrup, 1996, A role for the proteasome regulator PA28alpha in antigen presentation, Nature, 381, 166, 10.1038/381166a0 · DOI · Paper page
  68. R Holtappels, 2004, Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues, J Exp Med, 199, 131, 10.1084/jem.20031582 · doi:10.1084/jem.20031582
  69. AM Tatum, 2010, Direct presentation regulates the magnitude of the CD8+ T cell response to cell-associated antigen through prolonged T cell proliferation, J Immunol, 185, 2763, 10.4049/jimmunol.0903920 · DOI
  70. MF Kotturi, 2008, Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance, J Immunol, 181, 2124, 10.4049/jimmunol.181.3.2124 · DOI · Paper page
  71. NL La Gruta, 2010, Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion, J Clin Invest, 120, 1885, 10.1172/JCI41538 · DOI · Paper page
  72. IE Flesch, 2010, Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice, J Immunol, 184, 45, 10.4049/jimmunol.0900999 · DOI
  73. GJ Hammerling, 1982, Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice, Proc Natl Acad Sci U S A, 79, 4737, 10.1073/pnas.79.15.4737 · DOI · Paper page
  74. A Townsend, 1989, A mutant cell in which association of class I heavy and light chains is induced by viral peptides, Cold Spring Harb Symp Quant Biol, 54, 299, 10.1101/SQB.1989.054.01.038 · doi:10.1101/sqb.1989.054.01.038
  75. AW Purcell, 2001, Quantitative and qualitative influences of tapasin on the class I peptide repertoire, J Immunol, 166, 1016, 10.4049/jimmunol.166.2.1016 · DOI
  76. CA Sherwood, 2009, Rapid optimization of MRM-MS instrument parameters by subtle alteration of precursor and product m/z targets, J Proteome Res, 8, 3746, 10.1021/pr801122b · DOI
  77. AI Webb, 2004, The structure of H-2K(b) and K(bm8) complexed to a herpes simplex virus determinant: evidence for a conformational switch that governs T cell repertoire selection and viral resistance, J Immunol, 173, 402, 10.4049/jimmunol.173.1.402 · DOI

Cited by

Metadata

Authors
Croft, N. P., Smith, S. A., Wong, Y. C., Tan, C. T., Dudek, N. L., Flesch, I. E. A., Lin, L. C. W., Tscharke, D. C., & Purcell, A. W.
Venue
PLoS Pathogens
Published
2013-01-31
Volume
9
Issue
1
Pages
e1003129
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W1977492930
Cited by
160
References
9
FWCI
6.72
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.